Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone
International Cancer Conference Journal · 06.07.2026 · 15 (3) · 466-471
DOI: 10.1007/s13691-026-00882-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Cancer Conference Journal, online erschienen am 06.07.2026. Verfasst von Kyojiro Nakamura und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Thymic carcinomas frequently invade adjacent structures, rendering complete surgical resection difficult. Although multimodal treatment strategies, including chemotherapy, radiotherapy, and surgery, are employed, the prognosis of thymic carcinoma remains poor. Furthermore, it is exceedingly rare to achieve a pathological complete response following chemotherapy alone or in combination with radiotherapy. A 69-year-old man presented with an anterior mediastinal tumor. Surgical resection of the tumor was planned for diagnostic and therapeutic purposes. However, chest computed tomography (CT) performed approximately 1 month after the initial CT scan revealed rapid tumor growth from 38 to 52 mm, with suspected invasion into the left upper lobe and left main pulmonary artery. We performed a surgical biopsy for diagnosis, and pathological examination confirmed thymic carcinoma. Since radiation therapy was not feasible because of interstitial pneumonia, the patient received chemotherapy with carboplatin plus paclitaxel. Post-chemotherapy CT revealed tumor shrinkage to 15 mm and a clear border with the left main pulmonary artery. Radical surgery was subsequently performed, and the tumor was resected along with the left upper lobe, mediastinal fat tissue, and pericardium. The resected specimen did not contain any residual tumor cells, indicating a complete pathological response. The patient has remained free of recurrence for two years after surgery. This patient, who initially had an unresectable thymic carcinoma, achieved complete resection in response to chemotherapy with carboplatin and paclitaxel, resulting in a complete pathological response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan.
- Department of Thoracic Surgery, Kyushu University Hospital, Fukuoka, Japan.
- Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
ORCID-Profile: Fumihiko Kinoshita
Zitieren
APA
Nakamura, K., Kinoshita, F., Tanaka, K., Hashisako, M., Matsuda, M., Iwamoto, N., Matsubara, T., Takada, K., Oda, Y., Takenaka, T., & Yoshizumi, T. (2026). Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone. International Cancer Conference Journal, 15(3), 466-471. https://doi.org/10.1007/s13691-026-00882-2
Vancouver
Nakamura K, Kinoshita F, Tanaka K, Hashisako M, Matsuda M, Iwamoto N, et al. Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone. International Cancer Conference Journal. 2026;15(3):466-471. doi:10.1007/s13691-026-00882-2
BibTeX
@article{Nakamura2026,
author = {Nakamura, Kyojiro and Kinoshita, Fumihiko and Tanaka, Kentaro and Hashisako, Mikiko and Matsuda, Masakazu and Iwamoto, Naoya and Matsubara, Taichi and Takada, Kazuki and Oda, Yoshinao and Takenaka, Tomoyoshi and Yoshizumi, Tomoharu},
title = {Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone},
journal = {International Cancer Conference Journal},
year = {2026},
volume = {15},
number = {3},
pages = {466--471},
doi = {10.1007/s13691-026-00882-2}
}
EUVIMED